HighTower Advisors, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 43 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$39,000
-90.0%
10,500
-67.7%
0.00%
-100.0%
Q4 2022$390,000
+89.3%
32,500
+1.5%
0.00%0.0%
Q3 2022$206,000
+160.8%
32,004
+88.3%
0.00%
Q2 2022$79,000
-34.7%
17,000
+21.4%
0.00%
Q1 2022$121,000
-39.2%
14,0000.0%0.00%
Q4 2021$199,000
-67.7%
14,000
-50.0%
0.00%
-100.0%
Q3 2021$616,000
+58.4%
28,000
-3.4%
0.00%
+100.0%
Q2 2021$389,000
+60.1%
29,000
+20.8%
0.00%0.0%
Q1 2021$243,000
+326.3%
24,000
+77.8%
0.00%
Q4 2020$57,00013,5000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders